Close Menu

NEW YORK (GenomeWeb) – The New York State Department of Health recently approved two separate cancer whole-exome sequencing tests from Columbia University and from Weill Cornell Medicine and New York-Presbyterian.

Both tests aim to help doctors make therapy decisions for cancer patients.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.